Compare GLNG & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLNG | STVN |
|---|---|---|
| Founded | 1946 | 1949 |
| Country | Bermuda | Italy |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.5B |
| IPO Year | 2002 | 2021 |
| Metric | GLNG | STVN |
|---|---|---|
| Price | $51.20 | $21.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $50.63 | $25.67 |
| AVG Volume (30 Days) | ★ 1.1M | 484.8K |
| Earning Date | 11-21-2023 | 05-07-2026 |
| Dividend Yield | ★ 1.85% | 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.14 | $9.67 |
| Revenue Next Year | $8.66 | $9.99 |
| P/E Ratio | $80.48 | ★ $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.02 | $12.89 |
| 52 Week High | $57.79 | $28.00 |
| Indicator | GLNG | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 49.64 |
| Support Level | $48.19 | $20.17 |
| Resistance Level | $51.99 | $22.00 |
| Average True Range (ATR) | 1.53 | 0.75 |
| MACD | -0.12 | -0.13 |
| Stochastic Oscillator | 15.68 | 17.37 |
Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.